Girish N Aakalu is CHIEF BUSINESS OFFICER of GENOCEA BIOSCIENCES, INC.. Currently has a direct ownership of 74,459 shares of GNCA, which is worth approximately $0. The most recent transaction as insider was on Apr 04, 2022, when has been sold 963 shares (Common Stock) at a price of $1.25 per share, resulting in proceeds of $1,204. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 74.5K
0% 3M change
0% 12M change
Total Value Held $0

Girish N Aakalu Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 04 2022
SELL
Open market or private sale
$1,204 $1.25 p/Share
963 Reduced 1.28%
74,459 Common Stock
Mar 16 2022
SELL
Open market or private sale
$2,637 $1.1 p/Share
2,397 Reduced 3.08%
75,422 Common Stock
Mar 15 2022
BUY
Grant, award, or other acquisition
-
31,250 Added 28.65%
77,819 Common Stock
Mar 15 2021
BUY
Grant, award, or other acquisition
-
31,250 Added 50.0%
31,250 Common Stock
GNA

Girish N Aakalu

CHIEF BUSINESS OFFICER
Cambridge, MA

Track Institutional and Insider Activities on GNCA

Follow GENOCEA BIOSCIENCES, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GNCA shares.

Notify only if

Insider Trading

Get notified when an Genocea Biosciences, Inc. insider buys or sells GNCA shares.

Notify only if

News

Receive news related to GENOCEA BIOSCIENCES, INC.

Track Activities on GNCA